Chan Steffi K, Buitrago Blanco Manuel M, Feduska Nicholas J, Agopian Vatche G, Ebaid Samer S, Wang Tisha, Tamhaney Ami, Barjaktarevic Igor
Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Division of Neurocritical Care, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Clin Pract. 2024 Dec 29;15(1):5. doi: 10.3390/clinpract15010005.
Hepatopulmonary syndrome (HPS), defined by the presence of pulmonary vascular dilatations that cause right-to-left transpulmonary shunting of venous blood with a consequential increase in the alveolar-arterial oxygen gradient, is a relatively frequent complication of chronic liver disease. While orthotopic liver transplantation (OLT) is indicated and often curative in HPS patients with end-stage liver disease (ESLD), little is known about the peri- and post-operative-period risks of CVA in OLT recipients with HPS. : We report a case series of five non-consecutive OLT recipients with HPS who developed ischemic and/or hemorrhagic CVAs during or shortly after OLT, raising concern that the risks of neurological complications remain increased even after OLT. Our case series hopes to highlight the importance of close vigilance in this subset of patients, at a time when there may be multiple issues to be addressed in facilitating post-operative recovery.
肝肺综合征(HPS)的定义为存在肺血管扩张,导致静脉血从右至左经肺分流,进而使肺泡-动脉氧梯度增加,它是慢性肝病相对常见的并发症。虽然原位肝移植(OLT)适用于终末期肝病(ESLD)的HPS患者,且通常具有治愈性,但对于OLT术后HPS患者发生脑血管意外(CVA)的围手术期和术后风险却知之甚少。我们报告了一组5例非连续性OLT术后HPS患者的病例系列,这些患者在OLT期间或术后不久发生了缺血性和/或出血性CVA,这引发了人们对即使在OLT术后神经并发症风险仍会增加的担忧。我们的病例系列旨在强调在这部分患者中密切监测的重要性,因为在促进术后恢复时可能存在多个需要解决的问题。